This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: T31.3 (Burns involving 30-39% of body surface) | Special Copayment Reduction: V247 (Severe burn special copayment reduction: 5% copayment for 1 year from the registration date) |
| B. Synonyms | 30-39% TBSA burn, severe large-area burn, major burn 30-39% TBSA, burn of 30-39% of body surface area |
| C. Adult onset | Meets the criteria for severe burns and requires treatment in a specialized burn intensive care unit, prevention of multiorgan complications, and long-term rehabilitation. |
| 1. History | Development of specialized burn critical care medicine; leap in survival with the establishment of early excision and grafting strategies in the 1970s~80s |
| 2. Causes | Building fires, explosions, industrial accidents, extensive scalds; flame burns are most common, and reaching 30% TBSA or more requires a major accident |
| 3. Genetics | Genes related to susceptibility to multiple organ failure (IL-10, IL-1Ra, HLA); genetic regulation of the hypermetabolic response; genetic factors in long-term prognosis |
| 4. General epidemiology | About 8~12% of all burn admissions; mortality about 8~15% in young adults; 30~50% at age 60 and over; survival greatly improved with treatment in specialized burn centers |
| 5. Pathophysiology | Severe burn shock, systemic inflammatory response syndrome (SIRS), hypermetabolism, immunosuppression, cascade of multiple organ dysfunction |
| 6. Symptoms | Severe pain, symptoms of shock, dyspnea (inhalation injury), gastrointestinal symptoms, electrolyte imbalance, signs of sepsis |
| 7. Signs | Tachycardia, hypotension, oliguria, generalized edema, extensive burn wounds; Baux score 60~80; early signs of multiple organ dysfunction |
| 8. Screening | TBSA calculation by Lund-Browder and the Rule of Nines; LDI; Revised Baux; inhalation injury; organ function assessment |
| 9. Diagnosis | Whole-body burn map, depth classification, multiorgan function assessment; ICU monitoring; repeated blood tests; Revised Baux Score |
| 10. Treatment | Parkland fluids; early excision and grafting; use of allograft skin and artificial skin; intensive ICU care; nutrition and rehabilitation |
| 11. Prognosis | Trend of improving survival in specialized burn centers; prognosis for long-term functional recovery; infection and multiple organ failure are the main causes of death |
| 12. Prevention | Large-scale fire prevention systems; strengthened industrial safety; burn center transfer systems; education in rapid resuscitation |
| 13. References | Herndon DN et al. Effect of inhalation injury on mortality of burn patients … and 9 other papers |
The history of treatment of severe large-area burns of 30~39% TBSA coincides with the history of the development of specialized burn critical care medicine. Until the 19th century, large-area burns of this extent were almost invariably fatal, and death within days to weeks from post-burn shock, infection, and pneumonia was common. In the early 20th century, experience treating many burn patients accumulated in World War I, and experience managing large numbers of burn patients in World War II (1939~1945) became an important turning point in the development of burn medicine.
In the 1942 Cocoanut Grove fire, 492 people died, and this event gave a decisive impetus to the establishment of specialized burn care systems in the United States. After this event, a systematic fluid resuscitation protocol for burn patients was first developed at Massachusetts General Hospital in Boston, one of the first clinical protocols in burn care. In the 1950s~60s, fluid resuscitation formulas (Evans formula, Brooke formula, Parkland formula) were developed in succession, greatly reducing early mortality in severe burn patients.
In the 1970s, clinical application of early tangential excision was established, led by Janine Burke and Martin Hall. It was clinically demonstrated that rapidly removing the eschar and performing skin grafting reduces the risk of sepsis and shortens hospital stay, dramatically improving survival in patients with burns of 30% TBSA or more. Subsequently, allograft skin, artificial skin substitutes (Integra), and cell sheets (autologous cultured epithelium) were developed in succession, opening a new era in the treatment of large-area burns. Since the 2000s, negative pressure wound therapy, growth factor therapy, and stem cell-based skin regeneration have begun to be applied clinically.
Extensive burns reaching 30~39% TBSA occur mainly in large-scale fires or industrial accidents rather than simple accidents. Flame burns are the most common cause, including building fires in enclosed spaces, explosions of flammable liquids (gasoline, thinner, naphtha, etc.), gas explosions, factory fires, and fuel ignition after vehicle accidents. Extensive TBSA burns occur particularly when alcohol or thinner ignites while being handled, or when crowd crush and fire occur simultaneously.
Explosion burns are often accompanied by combined injuries with flame burns (blast noise injury, fragment injury, shock wave injury), and when whole-body flame exposure occurs in gas or chemical explosions, injury of 30% TBSA or more easily results. Industrial site burns result from molten metal spills, massive chemical exposure, and malfunction of heat-source equipment, and failure to wear protective equipment or follow safety procedures are major risk factors. In burns from fire accidents, delayed evacuation, inability to move (physical disability, old age, sleep), and blocked exits are important factors in extensive burns. Vulnerable groups include older adults living alone, people with intellectual disabilities, people with mental illness, and people with alcohol dependence.
In severe burns of 30~39% TBSA, the individual's genetic background plays an important role in the occurrence of systemic complications and in prognosis. Promoter polymorphisms of the IL-10 gene determine the intensity of the anti-inflammatory response, and in patients with low-expression IL-10 genotypes, the systemic inflammatory response after severe burns persists more strongly and the incidence of multiple organ failure is higher. Conversely, high-expression IL-10 genotypes may increase the risk of infection due to excessive immunosuppression, so a balanced anti-inflammatory response is associated with the best prognosis.
Polymorphisms of the IL-1Ra (Interleukin-1 receptor antagonist) gene determine the ability to antagonize the inflammatory effects of IL-1β, and patients with low-activity IL-1Ra genotypes have an increased risk of sepsis and ARDS after burns. HLA (Human Leukocyte Antigen) genotype affects the speed and intensity of immune rejection when allograft skin is used. In burns of 30% TBSA or more, when autologous skin donor sites are insufficient, allograft skin is used as a temporary wound cover, and the degree of HLA matching affects how long the grafted skin is retained.
Regarding the hypermetabolic response, polymorphisms of the insulin receptor substrate gene (IRS-1) and genes related to the insulin signaling pathway create individual differences in post-burn insulin resistance. The intensity of insulin resistance is associated with the duration of the hypermetabolic response and the rate of muscle protein breakdown, influencing nutritional support strategies. As for the genetic background of burn healing and scar formation, TGF-β1, COL1A1, and the MMP family apply in the same way.
Burns of 30~39% TBSA are a core category of severe burns, accounting for about 8~12% of all burn admissions. Worldwide, survival in burns of 30% TBSA or more has improved steadily over the past several decades. In the 1970s, survival in burns of 40% TBSA or more was below 50%, but specialized burn centers now achieve survival of over 80% even in 40% TBSA burns. This is the combined result of more precise fluid resuscitation, early surgical strategies, improved infection control, nutritional support, and advances in critical care medicine.
Mortality for burns of 30~39% TBSA is about 8~15% in young adults (aged 20~40) and rises sharply to 30~50% at age 60 and over. With inhalation injury, mortality at the same TBSA increases by an additional about 20~25%. According to data from Korean specialized burn centers, the average hospital stay for patients with burns of 30% TBSA or more is 6~10 weeks, with an average of 3~6 operations. The main causes of death are sepsis and septic shock (50~60%), multiple organ dysfunction (20~30%), and respiratory failure due to inhalation injury (10~20%).
Quality of life data for survivors of 30~39% TBSA burns are a very important epidemiologic indicator. About 50~60% of survivors are able to return to work, but an average rehabilitation period of 12~24 months is needed. PTSD occurs in about 25~40% of survivors, and studies indicate that when depression and anxiety disorders are combined, the prevalence of mental health problems exceeds 50%.
In burns of 30~39% TBSA, complex systemic pathophysiologic responses occur that go far beyond local wound damage. Systemic inflammatory response syndrome (SIRS) begins within hours after the burn and is characterized by tachycardia, tachypnea, abnormal body temperature, and abnormal white blood cell counts. At 30% TBSA or more, SIRS occurs in over 95% and is nearly universal. Massive release of inflammatory mediators increases systemic capillary permeability, leading to burn shock in which large amounts of plasma move out of the vessels.
Hypermetabolism is a unique systemic response that lasts from 48~72 hours after the burn for several months, with the basal metabolic rate rising to 150~200% of normal. Heart rate, oxygen consumption, carbon dioxide production, and body temperature all increase, and muscle protein breakdown (catabolism) is accelerated, causing rapid weight loss and loss of muscle strength. This hypermetabolic response results from the combined action of excess catecholamines secreted by the sympathetic nervous system and adrenal medulla, increased cortisol, and insulin resistance. Immune dysfunction shows a biphasic pattern in which initial excessive immune activation (SIRS) is followed by a state of immunosuppression (compensatory anti-inflammatory response syndrome, CARS). In the CARS phase, T lymphocyte anergy, reduced NK cell activity, and neutrophil dysfunction make the patient vulnerable to bacterial and fungal infections. Sepsis is a major cause of death in burns of 30% TBSA or more, with an incidence of about 20~35%.
Patients with burns of 30~39% TBSA present with a combination of extensive local symptoms and serious systemic symptoms. Symptoms of burn shock appear within hours after the burn, characterized by extreme thirst, dizziness, nausea and vomiting, anxiety, and severe fatigue. Symptoms of hypovolemia due to massive loss of exudate are prominent, and without treatment they progress to decreased consciousness.
Severe pain at the burn site is most prominent in superficially injured areas, and paradoxically decreases in deeply injured areas. Systemically, hypersensitivity may also appear in normal skin outside the burn site. As respiratory symptoms, when inhalation injury is present, hoarseness, cough, dyspnea, and wheezing appear from the start, and airway edema peaks 24~48 hours after the burn. Even without inhalation injury, acute lung injury (ALI) or ARDS due to the systemic inflammatory response can develop 2~5 days after the burn.
During inpatient treatment, severe procedural pain during dressing changes, musculoskeletal pain due to immobility, weakness and fatigue due to malnutrition, and high fever or hypothermia recur. With sepsis, high fever, chills, altered consciousness, and hypotension appear. During long-term treatment, scar itching (pruritus), scar pain, heat intolerance, and fatigue persist chronically.
Clinical signs in patients with burns of 30~39% TBSA are divided into findings of the burn wound itself and indicators of systemic instability. As abnormal vital signs, tachycardia (>100~120/min), tachypnea (>20~24/min), hypotension (systolic <90mmHg) or narrowed pulse pressure, and reduced urine output (<0.5mL/kg/hr) appear. Rectal temperature rises initially, but hypothermia can also develop due to massive heat loss. As burn wound findings, erythema, blisters, and exudation are distributed over 30~39% of total TBSA, and deeply injured areas are pale or mottled with decreased sensation.
Generalized edema peaks 24~48 hours after the burn, with severe edema not only at the burn site but also in unburned areas (eyelids, genitals, hands). When the Revised Baux Score is in the range of 60~80 (e.g., 40 years + 35% TBSA = 75), it corresponds to a predicted mortality of 5~15%, and with inhalation injury it becomes 75 + 17 = 92, greatly increasing the risk of death. Early signs of multiple organ dysfunction include elevated serum creatinine (reduced renal function), elevated liver enzymes (reduced liver function), thrombocytopenia (coagulation abnormalities), and increased serum lactate (reduced tissue perfusion).
Screening in burns of 30~39% TBSA is performed rapidly at the same time as emergency treatment. TBSA calculation is measured accurately by region using the Lund-Browder chart, and in children, applying the adult Rule of Nines as is produces large errors, so Lund-Browder must be used. Once TBSA is confirmed, the fluid volume for the first 24 hours is calculated with the Parkland formula (4 × kg × TBSA%) and administration begins immediately. Screening for inhalation injury: when there are facial or head and neck burns, a history of fire in an enclosed space, soot inhalation, hoarseness, or dyspnea, the airway is evaluated immediately by bronchoscopy.
Systemic tests include arterial blood gas analysis (pH, PaO2, PaCO2, lactate, carboxyhemoglobin), complete blood count, coagulation tests (PT, aPTT, fibrinogen), electrolytes, renal function, liver function, albumin, blood glucose, CRP, and procalcitonin. An ECG is essential for electrical burns or electrolyte abnormalities, and chest X-rays are used to assess inhalation injury and lung status. The Revised Baux Score is calculated immediately and used for initial prognostic communication and decisions on treatment intensity. Laser Doppler imaging (LDI) is used 48~72 hours after the burn to create a depth map of the entire burn area for surgical planning.
Diagnosis of burns of 30~39% TBSA is divided into a rapid initial clinical assessment and subsequent systematic in-depth assessment. In the initial ABCDE assessment, securing the Airway and stabilizing Breathing are the top priorities, and early endotracheal intubation should not be delayed when necessary. Creating a whole-body burn map, confirming TBSA, classifying depth, and calculating the Baux score are the standard diagnostic steps. ICU monitoring includes an arterial line (direct blood pressure measurement), a central venous catheter (CVP measurement, drug administration), and an indwelling urinary catheter (hourly urine output measurement), with a pulmonary artery catheter or PiCCO monitoring added as needed.
At the reassessment 48~72 hours after admission, the initial diagnosis is revised and the area by burn depth is confirmed. Surgical priorities are determined considering functionally important areas (face, hands, feet, joints), areas at risk of infection (perineum, axilla, neck folds), and the size of the area. For bacterial culture surveillance, burn wound swab cultures are performed 2~3 times a week to continuously monitor predominant species and antimicrobial susceptibility. Sepsis is determined according to the diagnostic criteria (Sepsis-3: infection + SOFA score ≥2), and immediate antibiotic administration and hemodynamic resuscitation are performed.
Fluid resuscitation: according to the Parkland formula, for a patient weighing 70kg with 35% TBSA, the fluid volume for the first 24 hours = 4 × 70 × 35 = 9,800mL, with 4,900mL given in the first 8 hours and 4,900mL over the following 16 hours. Fluid adequacy is assessed every hour by urine output (target: 0.5~1.0mL/kg/hr in adults). After the first 24 hours, colloid (albumin) is added to maintain plasma colloid osmotic pressure and prevent excessive fluid administration (fluid creep).
For surgical treatment, early tangential excision is performed within 5~7 days after the burn, with up to 20~25% TBSA excised and grafted at a time through staged surgery. When autologous donor sites are limited, cadaveric allograft is used as a temporary cover to close the wound quickly. Allograft skin prevents fluid loss and infection and is replaced with autologous graft skin within 2~4 weeks. Artificial skin (Integra Bilayer Matrix) can be used for dermal reconstruction, in a two-stage method in which it is covered with thin autologous skin after neovascularization. For nutritional support, tube feeding is started within 6 hours after the burn, aiming to provide sufficient protein (2.0g/kg/day) and high calories (non-protein calories 35~40kcal/kg/day). Early rehabilitation begins even during the ICU stay with passive joint motion and position changes and progresses gradually to active exercise and gait training once the grafts are stable.
The prognosis of burns of 30~39% TBSA differs markedly with the treatment setting and patient factors. When treated in a specialized burn center, survival in young adults (aged 20~45) reaches 85~92%, but when treated in a general hospital, mortality is 2~3 times higher. The main causes of death are sepsis/septic shock (50~60%), ARDS and multiple organ failure (20~30%), and early respiratory failure due to inhalation injury (10~15%). Timing of death shows two peaks: the first week after the burn (burn shock, airway problems) and weeks 2~4 (sepsis, multiple organ failure).
The key factors determining the long-term prognosis in survivors are the level of functional recovery and psychosocial adjustment. About 50~60% of survivors of 30~39% TBSA burns can return to work, requiring an average of 12~18 months of intensive rehabilitation. Hypertrophic scars and joint contractures occur in 50~70% of survivors, and some require reconstructive surgery. In Korea, medical cost support for patients registered for the severe burn special copayment reduction (V247) is maintained at a 5% copayment for 1 year from the registration date, easing the economic burden.
Because extensive burns of 30% TBSA or more occur in large fires or industrial accidents, prevention strategies must be approached at the structural and environmental level. Effective building fire prevention systems include expanding the scope of mandatory automatic sprinkler installation, duplicating fire detectors (smoke, heat, CO detectors), installing evacuation route signage and emergency lighting, and installing fire doors. It is important to comply with fire safety standards from the building design stage and to mandate regular fire drills in multi-use facilities. Strengthening industrial safety requires mandatory flame-resistant work clothing, stronger safety procedures for handling combustible materials and chemicals, minimizing human exposure through automation of high-risk processes, and establishing emergency response protocols for accidents.
Establishing a burn network and transfer system is also an important preventive strategy. Building a system for rapid transfer to specialized burn centers when burns occur, and education in correct initial treatment at the scene or in the first emergency department before transfer (20 minutes of cooling, early start of Parkland fluids), prevent aggravation of secondary injury. Home-visit safety inspection services for vulnerable groups (older adults living alone, people with alcohol dependence, people with limited mobility) are also an effective means of prevention at the societal level.
Herndon DN, Barrow RE, Rutan RL, Rutan TC, Desai MH, Abston S. Effect of inhalation injury on mortality of burn patients. J Trauma. 1988;28(3):290-294. DOI: 10.1097/00005373-198803000-00003. PMID: 3351975.
Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the Baux score. J Trauma. 2010;68(3):690-697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220427.
Jeschke MG, van Baar ME, Choudhry MA, et al. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.
Alvarado R, Chung KK, Cancio LC, Wolf SE. Burn resuscitation. Burns. 2009;35(1):4-14. DOI: 10.1016/j.burns.2008.03.008. PMID: 18675523.
Orgill DP. Excision and skin grafting of thermal burns. N Engl J Med. 2009;360(9):893-901. DOI: 10.1056/NEJMct0804451. PMID: 19246361.
Greenhalgh DG. Sepsis in the burn patient: a different problem than sepsis in the general population. Burns Trauma. 2017;5:23. DOI: 10.1186/s41038-017-0089-9. PMID: 28748182.
Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497-502. DOI: 10.1016/j.clnu.2013.02.012. PMID: 23582468.
Edgar D, Brereton M. Rehabilitation after burn injury. BMJ. 2004;329(7461):343-345. DOI: 10.1136/bmj.329.7461.343. PMID: 15297346.
Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958964.
Rowan MP, Cancio LC, Elster EA, et al. Burn wound healing and treatment: review and advancements. Crit Care. 2015;19:243. DOI: 10.1186/s13054-015-0961-2. PMID: 26067660.